Patents by Inventor Natsumi NISHIKATA

Natsumi NISHIKATA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210205252
    Abstract: Described herein are nutritional compositions, such as ketogenic compositions, leucine-enriched amino acid mixtures, etc., useful, for example, for dietary management of intractable epilepsy. In some embodiments, the disclosure relates to methods of inhibiting epileptic seizures in a subject comprising administering to the subject a leucine-enriched amino acid mixture.
    Type: Application
    Filed: March 24, 2021
    Publication date: July 8, 2021
    Applicant: AJINOMOTO CO., INC.
    Inventors: Susan GINGRICH, Robert REED, Kenji NAGAO, Natsumi NISHIKATA
  • Publication number: 20190228844
    Abstract: An evaluating method includes an evaluating step of evaluating a state of colorectal cancer for a subject to be evaluated using (i) a concentration value of at least one metabolite of bABA, N-Me-bABA, 1-Me-His, aABA, Aminoadipic acid, bAiBA, Cadaverine, Ethylglycine, GABA, Homoarginine, Hypotaurine, Kinurenine, N6-Acetyl-L-Lys, Putrescine, Serotonin, Spermidine, Spermine, ADMA, Homocitrulline, 3-Me-His, Hydroxyproline, Phosphoethanolamine, SDMA, Acylcarnitine (13:1), and EPA in blood of the subject or (ii) a value of a formula calculated using the concentration value of the metabolite and the formula including an explanatory variable to be substituted with the concentration value of the metabolite.
    Type: Application
    Filed: April 2, 2019
    Publication date: July 25, 2019
    Applicant: AJINOMOTO CO., INC.
    Inventors: Hidehiro NAKAMURA, Natsumi NISHIKATA, Akira IMAIZUMI, Kazutaka SHIMBO, Naoko ARASHIDA, Rumi NISHIMOTO
  • Publication number: 20190227071
    Abstract: An evaluating method includes an evaluating step of evaluating a state of pancreatic cancer for a subject to be evaluated using (i) a concentration value of at least one metabolite of N-Me-bABA, bABA, GABA, N6-Acetyl-L-Lys, 1-Me-His, aABA, Aminoadipic acid, bAiBA, Cadaverine, Ethylglycine, Homoarginine, Hypotaurine, Kinurenine, Putrescine, Serotonin, Spermidine, Spermine, ADMA, Homocitrulline, 3-Me-His, Hydroxyproline, Phosphoethanolamine, Acylcarnitine (13:1), and EPA in blood of the subject or (ii) a value of a formula calculated using the concentration value of the metabolite and the formula including an explanatory variable to be substituted with the concentration value of the metabolite.
    Type: Application
    Filed: April 2, 2019
    Publication date: July 25, 2019
    Applicant: AJINOMOTO CO., INC.
    Inventors: Hidehiro NAKAMURA, Natsumi NISHIKATA, Akira IMAIZUMI, Kazutaka SHIMBO, Naoko ARASHIDA, Rumi NISHIMOTO
  • Publication number: 20180017570
    Abstract: An evaluating method includes an evaluating step of evaluating a state of lung cancer for a subject to be evaluated using a concentration value of at least one of Homoarginine, GABA, 3-Me-His, ADMA, Spermine, Spermidine, Cystathionine, Sarcosine, aAiBA, bAiBA, Putrescine, N-Acetyl-L-lys, Hypotaurine, bABA, and Ethylglycine in blood of the subject.
    Type: Application
    Filed: September 26, 2017
    Publication date: January 18, 2018
    Applicant: AJINOMOTO CO., INC.
    Inventors: Naoko ARASHIDA, Rumi NISHIMOTO, Kazutaka SHIMBO, Hidehiro NAKAMURA, Natsumi NISHIKATA, Akira IMAIZUMI